Insider Trading Alert - AEGN, HII And CYH Traded By Insiders

Stocks with insider trader activity include AEGN, HII and CYH
By Brian Hamilton ,

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Crame.

Friday, March 6, 2015, 111 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $7.25 to $35,021,994.00.

Highlighted Stocks Traded by Insiders:

Aegion (AEGN) - FREE Research Report

Galvin Walter J, who is Director at Aegion, bought 3,000 shares at $17.41 on March 6, 2015. Following this transaction, the Director owned 12,000 shares meaning that the stake was boosted by 33.33% with the 3,000-share transaction.

The shares most recently traded at $17.45, up $0.04, or 0.23% since the insider transaction. Historical insider transactions for Aegion go as follows:

  • 4-Week # shares bought: 476
  • 4-Week # shares sold: 4,000
  • 12-Week # shares bought: 1,190
  • 12-Week # shares sold: 4,000
  • 24-Week # shares bought: 18,345
  • 24-Week # shares sold: 4,000

The average volume for Aegion has been 318,300 shares per day over the past 30 days. Aegion has a market cap of $671.4 million and is part of the industrial goods sector and materials & construction industry. Shares are down 6.82% year-to-date as of the close of trading on Friday.

Aegion Corporation is engaged in the research and development, manufacture, installation, coating and insulation, cathodic protection, distribution, and licensing of proprietary technologies and services for the protection and maintenance of infrastructure worldwide. Currently, there is 1 analyst who rates Aegion a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AEGN - FREE

TheStreet Quant Ratings

rates Aegion as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full

Aegion Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Huntington Ingalls Industries (HII) - FREE Research Report

Hawthorne Bruce, who is Corp VP General Counsel & Sec at Huntington Ingalls Industries, sold 5,000 shares at $142.35 on March 6, 2015. Following this transaction, the Corp VP General Counsel & Sec owned 34,062 shares meaning that the stake was reduced by 12.8% with the 5,000-share transaction.

The shares most recently traded at $139.63, down $2.72, or 1.95% since the insider transaction. Historical insider transactions for Huntington Ingalls Industries go as follows:

  • 4-Week # shares sold: 5,463
  • 12-Week # shares sold: 5,463
  • 24-Week # shares sold: 11,896

The average volume for Huntington Ingalls Industries has been 318,800 shares per day over the past 30 days. Huntington Ingalls Industries has a market cap of $6.8 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 21.88% year-to-date as of the close of trading on Friday.

Huntington Ingalls Industries, Inc. engages in designing, building, overhauling, and repairing ships primarily for the U.S. Navy and the U.S. Coast Guard. It operates in three segments: Ingalls Shipbuilding, Newport News Shipbuilding, and Other. The stock currently has a dividend yield of 1.14%. The company has a P/E ratio of 20.5. Currently, there are 4 analysts who rate Huntington Ingalls Industries a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HII - FREE

TheStreet Quant Ratings

rates Huntington Ingalls Industries as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Huntington Ingalls Industries Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Community Health Systems (CYH) - FREE Research Report

Portacci Michael T, who is Division President at Community Health Systems, sold 14,692 shares at $50.92 on March 6, 2015. Following this transaction, the Division President owned 41,460 shares meaning that the stake was reduced by 26.16% with the 14,692-share transaction.

The shares most recently traded at $48.96, down $1.96, or 4.01% since the insider transaction. Historical insider transactions for Community Health Systems go as follows:

  • 4-Week # shares sold: 20,339
  • 12-Week # shares sold: 20,339
  • 24-Week # shares sold: 23,339

The average volume for Community Health Systems has been 1.6 million shares per day over the past 30 days. Community Health Systems has a market cap of $6.0 billion and is part of the health care sector and health services industry. Shares are down 5.82% year-to-date as of the close of trading on Friday.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. The company has a P/E ratio of 38.8. Currently, there are 13 analysts who rate Community Health Systems a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYH - FREE

TheStreet Quant Ratings

rates Community Health Systems as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, attractive valuation levels, solid stock price performance, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Community Health Systems Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

Loading ...